DrugDashboards

Market view

dexmedetomidine hydrochloride in 0.9% sodium chloride · Injection

6 marketed package NDCs · 3 active manufacturers

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

Same drug class

Other molecules FDA puts in Central alpha-2 Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dexmedetomidine hydrochloride in 0.9% sodium chloride in shortage right now?
Yes. FDA currently lists Dexmedetomidine hydrochloride in 0.9% sodium chloride in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Dexmedetomidine hydrochloride in 0.9% sodium chloride?
4 companies have marketed Dexmedetomidine hydrochloride in 0.9% sodium chloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage nowDexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)Apr 10, 2020
  • In shortage nowDexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)Apr 10, 2020
  • In shortage nowDexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)Apr 10, 2020
  • In shortage nowDexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)Apr 10, 2020
  • In shortage nowDexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95)Apr 10, 2020

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.